Dr. Nancy Kerner is an NIMH-funded T32 Late-life Neuropsychiatric Disorder Clinical and Research fellow. Dr. Kerner is Assistant in Clinical Psychiatry at the College of Physicians and Surgeons, Columbia University. Dr. Kerner attended medical school in China and completed her psychiatry residency at Columbia University Presbyterian Hospital -Creedmoor Psychiatric Residency program. Dr. Kerner began to work with elderly patients as a treating psychiatrist and leader of a Geriatric Group Therapy at New York Presbyterian Hospital Outpatient Clinic during her senior year thus developed interest in Geriatric Psychiatry. Dr. Kerner completed her Clinical Geriatric Psychiatry Fellowship at Columbia University -Columbia Campus Track after completing her residency. During her clinical fellowship, Dr. Kerner’ training was focused on complex late-life neuropsychiatric illness and psychopharmacology. She was trained in different clinical settings, including the ECT service, long-term inpatient geriatric psychiatric unit, inpatient and outpatient Psychiatry Consultation Services, Behavioral and Memory Disorders Clinic, and Late-life Depression Clinic. Dr. Kerner is the first author of the original article Duloxetine Trial in Elderly with Dysthymia under the mentorship of Dr. D.P. Devanand and the first author of an extensive review article ECT Clinical Practice and Research in the Geriatric Population under the mentorship of Dr. Joan Prudic. Subsequently, Dr. Kerner started her clinical and research training in Late-life Neuropsychiatric Disorder under the primary mentorship of Dr. Steven Roose. Dr. Kerner’s research interests are the biological mechanisms that link cerebral small vessel disease and late-life depression, where ‘vascular depression’ is Dr. Roose’s expertise in clinical and research for the past 20 years. Dr. Kerner’s research has focused on the association between sleep apnea, late-life depression, and cognitive impairment.